Patents by Inventor Markus Huembelin

Markus Huembelin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150259705
    Abstract: The invention relates to a Rhodobacter host cell, comprising a nucleic acid encoding—enzymes of a mevalonate pathway for making isoprenyl pyrophosphate (IPP) and its isomer dimethylallyl pyrophosphate (DMAPP);—an enzyme having catalytic activity for the condensation of IPP and DMAPP into geranyl diphosphate (GPP) and—an enzyme having monoterpene synthase activity in the conversion of GPP into a monoterpene or sesquiterpene synthase activity.
    Type: Application
    Filed: July 18, 2013
    Publication date: September 17, 2015
    Inventors: Markus Huembelin, Matrinus Julius Beekwilder, Joannes Gerardus Theodorus Kierkels
  • Publication number: 20090226986
    Abstract: The present invention provides improved processes for the preparation of Coenzyme Q-10 (CoQ10) by fermentation of microorganisms of the genus Rhodobacter transformed with the mevalonate operon of Paracoccus zeaxanthinifaciens.
    Type: Application
    Filed: March 4, 2009
    Publication date: September 10, 2009
    Inventors: Alan Berry, Markus Huembelin, Rual Lopez-Ulibarri
  • Patent number: 7435571
    Abstract: The present Invention relates to enzymes involved in the Synthesis of Coenzyme Q-10, i.e., decaprenyl diphosphate (DPP) synthase and 4-hydroxybenzoate polyprenyltransferase, to isolated DNA encoding said enzymes and to methods for the microbial production of Coenzyme Q-10.
    Type: Grant
    Filed: February 13, 2004
    Date of Patent: October 14, 2008
    Assignee: DSM IP Assets B.V.
    Inventors: Markus Huembelin, Rual Lopez-Ulibarri, John B. Perkins, Ghislain Schyns
  • Patent number: 7422884
    Abstract: The present invention relates to modified mevalonate kinases that are less sensitive to feedback inhibition, and to polynucleotides encoding them. The invention further pertains to vectors comprising these polynucleotides and host cells containing such vectors. The invention provides a method for producing the modified enzyme and a method for producing isoprenoid compounds.
    Type: Grant
    Filed: June 10, 2004
    Date of Patent: September 9, 2008
    Assignee: DSM IP Assetts B.V.
    Inventors: Renyuan Bai, Markus Huembelin, Martin Lehmann, Rual Lopez-Ulibarri, Markus Wyss
  • Publication number: 20070141685
    Abstract: The present invention relates to modified mevalonate kinases that are less sensitive to feedback inhibition, and to polynucleotides encoding them. The invention further pertains to vectors comprising these polynucleotides and host cells containing such vectors. The invention provides a method for producing the modified enzyme and a method for producing isoprenoid compounds.
    Type: Application
    Filed: June 10, 2004
    Publication date: June 21, 2007
    Inventors: Renyuan Bai, Markus Huembelin, Martin Lehmann, Rual Lopez-Ulibarri, Markus Wyss
  • Patent number: 7232679
    Abstract: Isolated polynucleotides encoding polypeptides having the activity of enzymes in the mevalonate pathway are provided. These sequences are useful for recombinantly producing isoprenoid compounds, such as carotenoids, in particular zeaxanthin. Expression vectors, cultured cells, and methods of making isoprenoid compounds are also provided.
    Type: Grant
    Filed: May 13, 2005
    Date of Patent: June 19, 2007
    Assignee: DSM IP Assets B.V.
    Inventors: Alan Berry, Werner Bretzel, Markus Hümbelin, Rual Lopez-Ulibarri, Anne Françoise Mayer, Alexei A. Yeliseev
  • Publication number: 20060154349
    Abstract: Improved process for the preparation of CoQ10 by fermentation of microorganisms of the genus Rhodobacter transformed with the mevalonate operon of Paracoccus zeaxanthinifaciens.
    Type: Application
    Filed: June 29, 2004
    Publication date: July 13, 2006
    Inventors: Alan Berry, Markus Huembelin, Rual Lopez-Ulibarri
  • Publication number: 20060088920
    Abstract: The present Invention relates to enzymes involved in the Synthesis of Coenzyme Q-10, i.e., decaprenyl diphosphate (DPP) synthase and 4-hydroxybenzoate polyprenyltransferase, to isolated DNA encoding said enzymes and to methods for the microbial production of Coenzyme Q-10.
    Type: Application
    Filed: February 13, 2004
    Publication date: April 27, 2006
    Inventors: Markus Huembelin, Rual Lopez-Ulibarri, John Perkkins, Ghislain Schyns
  • Patent number: 6989257
    Abstract: Isolated polynucleotides encoding polypeptides having the activity of enzymes in the mevalonate pathway are provided. These sequences are useful for recombinantly producing isoprenoid compounds, such as carotenoids, in particular zeaxanthin. Expression vectors, cultured cells, and methods of making isoprenoid compounds are also provided.
    Type: Grant
    Filed: June 5, 2002
    Date of Patent: January 24, 2006
    Assignee: DSM IP Assets B.V.
    Inventors: Alan Berry, Werner Bretzel, Markus Hümbelin, Rual Lopez-Ulibarri, Anne Françoise Mayer, Alexei A. Yeliseev
  • Patent number: 6322995
    Abstract: The present invention provides a recombinant bacterium for the over-production of riboflavin. The recombinant bacterium has has been transformed by three or four vectors, two of which each comprise either a DNA sequence coding for the riboflavin synthesizing enzymatic activities of Bacillus subtilis or a DNA sequence which is substantially homologous and one or more transcription elements and a third and/or fourth vector comprising either a DNA sequence coding for the ribA gene product of Bacillus subtilis or a DNA sequence which is substantially homologous and optionally a transcription element whereby one or a plurality of copies of each of these vectors has/have been integrated at three or four different sites within the bacterium's chromosome.
    Type: Grant
    Filed: July 23, 1997
    Date of Patent: November 27, 2001
    Assignee: F. Hoffmann-La Roche AG
    Inventors: Hans-Peter Hohmann, Markus Hümbelin, Adolphus van Loon, Walter Schurter